PDGFRB and neoplasm: In our previous work, we prepared the monomeric Z09591 affibody, designated ZPDGFRβ, and found that it showed PDGFRβ-dependent pericyte binding and thus increased the tumor uptake of fused anti-cancer proteins (Tao et al., 2017).